Clinical Trials on Nephrolithotomy, Percutaneous in Hong Kong
Total 9 results
-
Chinese University of Hong KongRecruiting
-
Samsung Medical CenterCompletedPercutaneous Coronary Intervention | Erythrocyte Transfusion | RevascularizationKorea, Republic of
-
Samsung Medical CenterCompletedPercutaneous Coronary Intervention | Erythrocyte Transfusion | RevascularizationKorea, Republic of
-
Duke UniversityAcist Medical SystemsCompletedPercutaneous Coronary InterventionUnited States
-
Samsung Medical CenterCompletedAdherence, Medication | Percutaneous Coronary Intervention | Compliance, Medication | Platelet Aggregation Inhibitors | Hydroxymethylglutaryl-coa Reductase Inhibitors | Persistence, MedicationKorea, Republic of
-
CathWorks Ltd.Cardiovascular Research Foundation, New YorkRecruitingPercutaneous Coronary InterventionUnited States, Israel
-
Jesse Brown VA Medical CenterTerminatedPercutaneous Coronary Intervention | Optical Coherence Tomography | In-stent Coronary Artery RestenosisUnited States
-
Boehringer IngelheimCompletedAtrial Fibrillation | Percutaneous Coronary InterventionCanada, United States, Spain, Korea, Republic of, Australia, Germany, Taiwan, Hong Kong, Thailand, United Kingdom, Turkey, Netherlands, Ireland, Hungary, Croatia, Colombia, Israel, Singapore, Italy, New Zealand, Greece, Mexico, Norway, Swed... and more
-
AstraZenecaCompletedAcute Coronary Syndrome | Percutaneous Coronary InterventionKorea, Republic of, Japan, Taiwan